New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
09:11 EDTBKS, CVRR, OMI, AERI, GIS, PXD, MDCI, NSPH, MON, IMS, SQBG, GLNG, BMYOn The Fly: Pre-market Movers
HIGHER: Barnes & Noble (BKS), up 7.7% after board authorizes management to separate Retail, Nook Media units... Monsanto (MON), up 5% after reporting better than expected Q3 results, raising its full year EPS outlook to the upper end of its previous guidance range and announcing a new $10B share repurchase authorization... IMS Health (IMS), up 7.7% after acquiring certain Cegedim businesses for $520M... Nanosphere (NSPH), up 16.2% after receiving 510(k) clearance for bacterial portion of Verigene EP test... Aerie Pharmaceuticals (AERI), up 37% after its trial of Roclatan achieved its primary efficacy endpoint... Medical Action (MDCI), up 94% after Owens & Minor (OMI) acquires the company for $13.80 per share in cash... Sequential Brands (SQBG), up 15% after acquiring Galaxy Brand for $100M cash, 13.75M shares... Pioneer Natural (PXD), up 2.3% after media reports that the company got U.S. permission to ship a type of light oil known as condensate... Bristol-Myers Squibb (BMY), up 2% after a Phase 3 study of nivolumab was halted early due to superior data. LOWER: General Mills (GIS), down 3.7% after Q4 earnings fall below analyst's consensus... Lindsay Corp. (LNN), down 5% after earnings miss, saying Iraq contract now more difficult to complete... Golar LNG (GLNG), down 2% after 11M share offering priced at $54 per share... CVR Refining (CVRR), down 7% after 6M share secondary offering of common units price at $26.07.
News For BKS;MON;GIS;BMY;NSPH;AERI;GLNG;MDCI;OMI;SQBG;PXD;CVRR;IMS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 8, 2015
16:34 EDTSQBGSequential closes Simpson acquisition, raises FY15 revenue to $78M-$81M
Sequential Brands announced that it has closed the acquisition of the Jessica Simpson brand. The company has acquired a majority interest in the brand, including the Jessica Simpson Collection master license and other rights. The company is projecting forward 12-month royalty revenues of $88M-$90M and $53.5M-$55M of adjusted EBITDA from the company's total brand portfolio. For FY15, the company is increasing projected revenue to $78M-$81M and increasing projected adjusted EBITDA to $48.5M-$50.5M. Current revenue consensus is $60.97M
13:39 EDTPXDPioneer Natural backs FY15 CapEx view $1.85B
Subscribe for More Information
11:22 EDTMONOptions with decreasing implied volatility
Subscribe for More Information
11:07 EDTMONOptions with decreasing implied volatility
Subscribe for More Information
08:08 EDTBMYuniQure price target raised to $50 from $28 at Leerink
Subscribe for More Information
08:06 EDTBMYBristol-Myers completes acquisition of Flexus Biosciences
Bristol-Myers Squibb Company announced that it has completed the previously announced planned acquisition of Flexus Biosciences, Inc. The transaction includes full rights to F001287, Flexus’ lead preclinical, small-molecule IDO1-inhibitor targeted for IND filing in the second half of 2015 and an IDO/TDO discovery program that includes its IDO-selective, IDO/TDO dual and TDO-selective compound libraries. A newly formed entity established by the current shareholders of Flexus will retain, from and after the closing, all non-IDO/TDO assets of Flexus including those related to Flexus’ Phase 1 FLT3 and CDK4/6 inhibitor, its earlier stage small-molecule Treg cancer immunotherapy programs, and its current personnel and facilities.
April 7, 2015
15:15 EDTGISGeneral Mills volatility elevated as shares near record high
Subscribe for More Information
11:56 EDTNSPHNanosphere announces reverse split of common stock
Subscribe for More Information
11:42 EDTNSPHNanosphere solicited by Navy for Verigene RV+ test contract
Subscribe for More Information
11:09 EDTMONOptions with decreasing implied volatility
Subscribe for More Information
07:14 EDTBMYEyeforpharma to hold a summit
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.
06:38 EDTMONChinese citizens demand to see Monsanto test results, WantChinaTimes says
Subscribe for More Information
April 6, 2015
16:17 EDTBMYOn The Fly: Closing Wrap
Subscribe for More Information
12:44 EDTBMYOn The Fly: Midday Wrap
Subscribe for More Information
12:13 EDTBMYuniQure price target raised to $40 from $35 at Piper Jaffray
Subscribe for More Information
08:38 EDTSQBGSequential Jessica Simpson deal creates growth opportunities, says Roth Capital
Subscribe for More Information
08:13 EDTBMYCelldex announces initiation of Phase 1/2 study of Varlilumab combination
Subscribe for More Information
07:54 EDTSQBGSequential Brands remains a top small-cap pick, says Canaccord
Subscribe for More Information
07:33 EDTBMYBristol-Myers announces strategic collaboration with uniQure
Subscribe for More Information
April 5, 2015
09:02 EDTMONMonsanto 'deserves a second look', Barron's says
Fears regarding Monsanto seem to be "overdone" and are not related to the stock's fundamentals, Barron's argues in its 'The Trader' column. Long term investors should keep the stock at current levels, the paper adds. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use